Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Nov;26(12):1672-6.

Diagnostic utility of C-terminal parathyrin measurement as compared with measurements of N-terminal parathyrin and calcium in serum

  • PMID: 7428150

Diagnostic utility of C-terminal parathyrin measurement as compared with measurements of N-terminal parathyrin and calcium in serum

M Simon et al. Clin Chem. 1980 Nov.

Abstract

We compared results obtained from two parathyrin (parathyroid hormone) assays with differing specificities, using sera from 172 normal donors and from 98 patients with disorders of calcium regulation. Intact parathyrin was measured in both assays; the C-parathyrin assay also measured the 53-84 amino acid C-terminal hormone fragment; the N-parathyrin assay also measured the 1-34 N-terminal fragment. The reference interval for the C-parathyrin assay (860-3720 int. units/L; 430-1860 ng/L) was markedly higher than for the N-parathyrin assay (460-1260 int. units/L; 230-630 ng/L), a finding consistent with the longer half-life of C-parathyrin fragments in human circulation. Mean C-parathyrin in primary hyperparathyroid sera--5720 (SD 2760) int. units/L or 2860 (SD 1380) ng/L--clearly exceeded the reference interval and values for sera from patients with non-parathyroid malignancy [1740 (SD 760) int. units/L; 870 (SD 380) ng/L]. Secondary hyperparathyroid patients also had supranormal C-parathyrin values: 6100 (SD 2720) int. units/L; 3050 (SD 1360) ng/L. We found no consistent correlation between parathyrin and serum calcium in any clinical group. The two parathyrin assays showed about equal diagnostic power, but their results could not be used interchangeably in sequential monitoring of patients.

PubMed Disclaimer